MUKKABSEMukka Proteins LtdLowNeutral
Announced Tue, 12 May · 17:06 IST

Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve 1. The audited financial results ....

Debt Equity ThresholdResults View source PDF

MUKKA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹24.01
prior close
₹23.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1+1.7+1.1+1.2-0.2-0.7-3.8-4.2-6.0-6.2-8.2+0.2+0.6
Up moveDown movePending
AI summary

Mukka Proteins Ltd has scheduled a Board meeting on 15th May 2026 to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2026. The meeting also includes agenda items for raising funds via issuance of non-convertible debentures (NCDs) up to Rs. 25 crore through Electronic Bidding Platform on a private placement basis, with a separate proposal for additional NCD issuance up to Rs. 50 crore in one or more tranches over time. The total potential debt raise is Rs. 75 crore. The trading window for insiders has been closed since 1st April 2026 until 48 hours after the results are declared.

Likely market impact

The planned NCD issuance of up to Rs. 75 crore indicates the company is seeking to raise debt capital, which could increase leverage. Actual financial results and their implications for shareholders will be known only after the meeting.